Clinical Trial Update: Safety Study of Pyridostigmine in Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating pyridostigmine in heart failure has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: NYU Langone Health | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2016-10-25